USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Mallinckrodt Hospital Products IP Unlimited Company

USPTO PatentsView assignee record — 84 granted patents across 29 technology areas, active 2016–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR).

84
Total patents granted
29
CPC technology areas
16.6
Avg claims per patent
-25%
5-year filing velocity

The verdict

Mallinckrodt holds 84 US patents across 29 technology areas — rank #4,250 of 50,000 tracked assignees.

#4,250
of 50,000 US assignees by volume
Top 24%
by Innovation Score (45.0/100)
16.6
avg claims per patent
-25%
filing velocity, last 5 yrs

Portfolio overview

Mallinckrodt Hospital Products IP Unlimited Company has been granted 84 US utility patents between 2016 and 2025, placing Mallinckrodt Hospital Products IP Unlimited Company at rank #4,250 across all assignees tracked by PlainPatent. This portfolio spans 29 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.6 claims per patent with primary concentration in A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR). As a Foreign Corporation, Mallinckrodt Hospital Products IP Unlimited Company is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 45.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 36 grants, compared with 48 in the 2015–2019 window — a -25% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Mallinckrodt Hospital Products IP Unlimited Company's 16.6 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 29 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Mallinckrodt Hospital Products IP Unlimited Company against peers pursuing similar technology classes.

How does Mallinckrodt compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows Mallinckrodt holds 84 patents — placing it at rank #4,250 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

Mallinckrodt's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

45 Top 24% higher than 76% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). This entry sits in this band. 50–60: 5,058 US assignees (10%). Above this entry. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView — PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

-50510152025 2016201720182019202020212022202320242025 1
USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table
Mallinckrodt Hospital Products IP Unlimited Company patent grants by year, 2015–2025
Year Patents Granted Share of Period
2016 6 7.1%
2017 10 11.9%
2018 10 11.9%
2019 22 26.2%
2020 18 21.4%
2021 12 14.3%
2022 1 1.2%
2023 2 2.4%
2024 2 2.4%
2025 1 1.2%

Which technologies does Mallinckrodt Hospital Products IP Unlimited Company patent most?

Top 15 of 29 technology areas

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Multi-domain
Claim Depth Standard
Velocity Declining

Where it ranks

Overall rank by patents

#4,250

Across all tracked assignees

Innovation Score

45.0 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Mallinckrodt Hospital Products IP Unlimited Company hold?
Mallinckrodt Hospital Products IP Unlimited Company holds 84 US granted patents filed between 2016 and 2025, spanning 29 technology areas.
What is Mallinckrodt Hospital Products IP Unlimited Company's Innovation Score?
Mallinckrodt Hospital Products IP Unlimited Company has an Innovation Score of 45.0 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Mallinckrodt Hospital Products IP Unlimited Company focus on?
Mallinckrodt Hospital Products IP Unlimited Company's top technology area is A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR) with 67 patents. The company has filed patents in 29 CPC subclasses total.
Is Mallinckrodt Hospital Products IP Unlimited Company's patent filing rate increasing or decreasing?
Mallinckrodt Hospital Products IP Unlimited Company's recent filing velocity is -25% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for Mallinckrodt Hospital Products IP Unlimited Company's patents?
Mallinckrodt Hospital Products IP Unlimited Company's patents average 16.6 claims each. This falls within the standard range, providing solid legal coverage.
How is the Mallinckrodt Hospital Products IP Unlimited Company patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

How to use this portfolio

Mallinckrodt's 84 grants land it in the top 24% by Innovation Score — but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance — Mallinckrodt ranks #4,250 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in A61M — see who else leads that technology area. A61M leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity — not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Explore the patent dataset

Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Data sources used on this page
  • USPTO PatentsView — the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) — the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search — the official interface to verify the status of any individual patent. ppubs.uspto.gov